Target intelligence / Profile preview

Reactive oxygen species and redox-active metals (ROS/Metals)

Target
ROS/Metals
Molecular classification
Small molecule, Inorganic ion, Free radical
01

Overview

Reactive oxygen species (ROS) and redox-active metals, such as iron and copper, are pivotal mediators of cellular redox homeostasis and oxidative stress (Halliwell & Gutteridge, 2015). ROS, including superoxide and hydrogen peroxide, are natural byproducts of mitochondrial metabolism and enzymatic activities like NADPH oxidase, while redox-active metals facilitate the Fenton reaction to generate highly toxic hydroxyl radicals (Sies et al., 2017; Winterbourn, 1995). Pathological accumulation of these species is a hallmark of neurodegenerative diseases like Alzheimer's and Parkinson's, as well as cardiovascular disorders and metal overload syndromes like hemochromatosis (Jomova & Valko, 2011). Pharmacological strategies target these species through scavengers that neutralize radicals and chelators that sequester labile metals to prevent radical formation (Kalinowski & Richardson, 2005). While effective in reducing oxidative damage, these therapies must be carefully managed to avoid disrupting essential redox signaling and causing mineral deficiencies (Forman et al., 2014).

Other names
Free radicalsOxidantsLabile metal ionsTransition metalsReactive oxygen speciesRedox-active metal ions
02

Mechanism of action

Direct neutralization of reactive oxygen species through electron donation (scavenging) and sequestration of transition metal ions to prevent the catalytic formation of hydroxyl radicals via the Fenton reaction (chelation) (Halliwell, 2011; Mobarra et al., 2016).

03

Biological functions

Redox signalingCellular homeostasisOxidative stress responseMetabolic byproduct
04

Disease associations

Neurodegenerative diseaseCardiovascular diseaseCancerInflammationIschemia-reperfusion injuryMetal overload disorders
05

Safety considerations

Depletion of essential trace metalsPro-oxidant activityGastrointestinal distressNephrotoxicityInterference with physiological redox signaling
06

Interacting drugs

N-acetylcysteine

8 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)8-hydroxy-2'-deoxyguanosine (8-OHdG)Protein carbonylsSerum ferritinIsoprostanes

Beyond the preview

Go deeper on Reactive oxygen species and redox-active metals (ROS/Metals).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reactive oxygen species and redox-active metals (ROS/Metals).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call